Protocol summary
-
Study aim
-
Evaluation of the effect of Foeniculum vulgare fruit and Echium amoenum Flower Combination on the severity of Physical and psychological symptoms of premenstrual syndrome
-
Design
-
Phase 3 randomized triple-blind clinical trial of three witnessed blind groups, including an intervention group and a placebo group
-
Settings and conduct
-
The personal information form and PSST will be filled out by women referring to the traditional medicine clinic of Imam Reza Hospital in Mashhad for initial diagnosis. After reviewing the inclusion and non-inclusion criteria, eligible individuals will complete the DRSP for two months. After final confirmation, 80 samples will be randomly selected and complete a quality of life and temperament questionnaire. The permutation block method will be used to assign individuals to study groups. Sequence generation will be by random allocation software. The test group will receive Echium and fennel capsules and the control group will receive placebo. The study time is 2 cycles and during it the DRSP is completed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion:
Age 18 to 35 years
Regular menstruation for 6 months
Bleeding 3 to 9 and intervals 24 to 35 days
Complete the conscious consent form
minimum score of 19 from PSST
non-Inclusion:
History of mental illness, surgery, estrogen-related cancers, thyroid, liver, kidney disease, diabetes, hypertension
Death of a loved one in the last six months
use of anti-anxiety and anti-depressant, estrogen and progesterone drugs in the last three months
Taking herbal, vitamin and mineral supplements over the past month
allergy to Echium and fennel
Pregnancy, lactation
-
Intervention groups
-
Intervention: capsules (with a dose of 2 grams of Echium and 1 gram of fennel per day),in the second two weeks, In two cycles.
placebo: starch capsule
-
Main outcome variables
-
The rate of changes in the severity of symptoms of PMS
General information
-
Reason for update
-
The closure of the dormitories due to the prevalence of COVID-19 caused a change in the sampling location, followed by a change in the entry criteria (being single) and the non-entry criteria (pregnancy and lactation).
Due to the termination of the previous statistics consultant's cooperation with the university and the change of the consultant, the change of randomization method and statistical software was done according to his opinion.
For ease of swallowing by the patient, the volume of capsules was reduced and the dose was increased.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20200530047600N1
Registration date:
2020-07-18, 1399/04/28
Registration timing:
prospective
Last update:
2021-09-21, 1400/06/30
Update count:
1
-
Registration date
-
2020-07-18, 1399/04/28
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2021-09-23, 1400/07/01
-
Expected recruitment end date
-
2022-03-19, 1400/12/28
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Evaluation of the effect of Foeniculum vulgare fruit and Echium amoenum Flower Combination on the severity of Physical and psychological symptoms of premenstrual syndrome
-
Public title
-
Evaluation of the effect of Foeniculum vulgare fruit and Echium amoenum Flower Combination on the severity of Physical and psychological symptoms of premenstrual syndrome
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Age 18 to 35 years
Regular menstruation for the past 6 months,
Bleeding period 3 to 9 days and two bleeding intervals 24 to 35 days,
Complete the conscious consent form
Get a minimum score of 19 from the PSST questionnaire
Exclusion criteria:
History of mental illness, surgery, estrogen-related cancers, thyroid, liver and kidney disease, diabetes and hypertension
Death of a loved one in the last six months
The use of anti-anxiety and anti-depressant drugs in the last three months,
The use of estrogen and progesterone medications in the last three months,
Taking herbal medicines and vitamin and mineral supplements over the past month,
History of allergy to Echium and fennel
Pregnancy and lactation
-
Age
-
From 18 years old to 35 years old
-
Gender
-
Female
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Investigator
- Outcome assessor
- Data analyser
-
Sample size
-
Target sample size:
80
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
Permuted block randomization
Unit: Individual
It is not stratified
Tools: random allocation statistical software
Regarding concealment: A person outside the design will prepare sealed envelopes based on the random allocation sequence created and provide them to the executors.
-
Blinding (investigator's opinion)
-
Triple blinded
-
Blinding description
-
The same capsules, with the same number, are placed in similar enveloped envelopes (from 1 to 80) based on a random assignment list by a person outside the research design.The study subjects receive the capsules monthly and in envelopes with the code. Participants, researchers, data evaluators, and data analysts are unaware of how the code is assigned.
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2020-05-23, 1399/03/03
-
Ethics committee reference number
-
IR.MUMS.REC.1399.276
Health conditions studied
1
-
Description of health condition studied
-
Premenstrual Syndrome
-
ICD-10 code
-
N94.3
-
ICD-10 code description
-
Premenstrual tension syndrome
Primary outcomes
1
-
Description
-
The rate of change in the severity of symptoms of premenstrual syndrome
-
Timepoint
-
Before the intervention, the first menstrual cycle after the intervention, the second menstrual cycle after the intervention
-
Method of measurement
-
Daily Record of Severity of Problems (DRSP)
Secondary outcomes
1
-
Description
-
The relationship between general temperament and the severity of symptoms
-
Timepoint
-
At the beginning of the study
-
Method of measurement
-
Daily Record of Severity of Problems (DRSP), Mojahedi Mizaj Questionnaire(MMQ)
2
-
Description
-
Changes in the quality of life in the intervention and control groups
-
Timepoint
-
Before and after the intervention
-
Method of measurement
-
Short-Form Health Survey questionnaire(SF-36)
3
-
Description
-
possible side effects
-
Timepoint
-
During the intervention
-
Method of measurement
-
Patient report
4
-
Description
-
The relationship between general temperament and the type of symptoms
-
Timepoint
-
At the beginning of the study
-
Method of measurement
-
Daily Record of Severity of Problems (DRSP), Mojahedi Mizaj Questionnaire(MMQ)
Intervention groups
1
-
Description
-
Intervention group: The test group received oral capsules containing Echium and fennel at a dose of 2 grams of Echium and 1 gram of fennel fruit (Ground and granulated) during the day, three times a day with a glass of lukewarm water for the second two weeks of Cycle in two consecutive cycles.
-
Category
-
Treatment - Drugs
2
-
Description
-
Control group: The control group will receive a placebo capsule containing starch with the conditions of the intervention group.
-
Category
-
Placebo
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Mashhad University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available